Log In
Print
BCIQ
Print
Print this Print this
 

Benet, risedronate (once-monthly Actonel, once-monthly Benet) (NE-58095)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionAntiresorptive pyridinyl bisphosphonate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation

Partner

Ajinomoto Co. Inc.; Eisai Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today